# BKEMV

NDC: 55513-180
Generic name: eculizumab-aeeb
Labeler / Manufacturer: Amgen Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20250301

FDA application: BLA761333

## Active ingredients

- ECULIZUMAB: 300 mg/30mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-180"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-180
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=002f9748-b0e8-4b6e-a38b-56930a839491